<rss version='2.0' >

                    <channel>

                    <title><![CDATA[Current Computer Science (Volume 4 - Issue 1)]]></title>

                    <link>https://www.benthamscience.com/journal/224</link>

                    <description>

                    RSS Feed for Journals <![CDATA[Current Computer Science]]> | BenthamScience

                    </description>

                    <generator>EurekaSelect (+https://www.benthamscience.com)</generator>

                    <pubDate>2026-03-31</pubDate>

                    <image>

                    <title><![CDATA[Current Computer Science (Volume 4 - Issue 1)]]></title>

                    <url></url>

                    <link>https://www.benthamscience.com/journal/224</link>

                    </image><item><title><![CDATA[Artificial Intelligence in Pharmacovigilance]]></title><link>https://www.benthamscience.com/article/145217</link><pubDate>2026-03-31</pubDate><description><![CDATA[Pharmacovigilance (PV) is a data-driven method that quickly identifies medication safety risks by processing reports of suspected Adverse Events (AEs) and extracting health data. The first steps in the PV case processing cycle include data collection, data entry, coding, preliminary validity and completeness checks, and medical evaluation for severity, seriousness, expectation, and causality. Afterward, a report is submitted, quality is checked, and data storage and maintenance are performed. This process is costly and time-consuming, as it requires both a workforce and technology. Conversely, artificial intelligence (AI) is used to reduce this time investment and increase data accuracy. AI includes machine learning methods like deep learning and natural language processing, which can recognize and retrieve information on adverse drug occurrences. By doing so, it is possible to optimize the pharmacovigilance process and improve the tracking of documented adverse medication occurrences. AI's advancement in pharmacovigilance raises concerns about potential changes in drug safety professionals' roles, prompting curiosity about their future in an AI-assisted workplace. Artificial Intelligence (AI) should augment human intelligence, not replace human specialists. It's crucial to highlight and ensure AI improves PV more than it causes problems. The pharmaceutical business faces significant obstacles and opportunities, especially when it comes to implementing and employing advanced Information Technology (IT) in Pharmaceutical Monitoring Systems (PMS). Automation improves PV in several ways (e.g., boosting data quality or improving consistency). Several themes are discussed, outlining the challenges encountered, exploring potential solutions, and emphasizing the need for further research. The accepted use case involves automating the workflow in the case of ICRS.]]></description> </item><item><title><![CDATA[Transforming Pharmaceutical Manufacturing: The Role of Machine Learning Algorithms and Emerging Trends]]></title><link>https://www.benthamscience.com/article/147347</link><pubDate>2026-03-31</pubDate><description><![CDATA[The application of machine learning (ML) algorithms is causing a revolutionary change in the pharmaceutical production sector, providing previously unheard-of chances to improve productivity, precision, and creativity. From supply chain management and predictive maintenance to process optimization and quality assurance, machine learning approaches are transforming many aspects of drug manufacturing. These algorithms greatly lower production costs and minimize errors by utilizing large datasets to provide real-time analysis, anomaly detection, and predictive insights. The potential of these technologies to simplify intricate industrial processes is further enhanced by emerging trends like automation, sophisticated process control systems, and the integration of machine learning with digital twins. With an emphasis on important applications such as formulation optimization, adaptive process controls, and predictive modeling for regulatory compliance, this paper examines the changing field of machine learning in pharmaceutical production. It emphasizes how ML and Industry 4.0 technologies-like robotics and the Internet of Things (IoT)-work together to create smart industrial environments. The essay also discusses issues like algorithm openness, data privacy, and the requirement for a trained staff in order to fully utilize machine learning in this field. A key tool in addressing the rising demand for complicated biologics and tailored medications, machine learning (ML), is emerging as the pharmaceutical industry shifts to more flexible, economical, and sustainable production models. This review highlights the revolutionary impact of machine learning (ML)-driven production and offers a roadmap for its successful adoption in the pharmaceutical industry by analyzing its present status and potential future developments.]]></description> </item><item><title><![CDATA[Determination of Age and Sex from Human Bite Mark Using Artificial Intelligence]]></title><link>https://www.benthamscience.com/article/147609</link><pubDate>2026-03-31</pubDate><description><![CDATA[<p> Introduction: Bite mark analysis plays a major role in forensic science and crime investigation. It helps in the process of identifying individuals who are involved in criminal activities. It is commonly encountered in crime scenes such as rape, murder, child abuse etc. The process of analysis and the comparison of the bite mark, which is produced by the suspect’s dentition, which is left on human skin, is not an easy task, it is a difficult procedure. </p> <p> Objectives: With the help of Artificial Intelligence, the analysis and comparison of unknown bite marks will become more accurate and reliable. The purpose of this study is to create and validate a Convolutional Neural Network (CNN) model for determining the age and sex of individuals from bite mark samples. </p> <p> Methods: A dataset comprising 50 bite mark images (25 males and 25 females) from individuals belonging to the 18-25 age category was collected and analyzed using the CNN’s model. </p> <p> Results and Discussion: The result shows that the CNN’s model has high accuracy and strong generalization capabilities in the process of classification of bite marks on the basis of sex and age, and the accuracy in sex determination is 97% and in the case of age determination in male it is again 97% and age determination in case of female it is 98%. The performance of this model of architecture indicates that it can serve as a potential tool for the process of investigation and make the identification of the individuals who were involved in the crime more easily. The precision and accuracy of this method is very high due that it can assist in the process more effectively and efficiently. By determining the age and sex of an unknown bite mark, the list of the suspected individuals can be narrowed down and it is very helpful for the investigation process. </p> <p> Conclusion: These findings indicate that the CNN model can be used as a valuable technique in forensic investigations, offering a novel, AI-based approach to improve the accuracy and precision of bite mark analysis for age and sex determination. This study also paves the path for additional study and development in AI-driven forensic science. </p>]]></description> </item><item><title><![CDATA[Artificial Intelligence in Herbal Drug Authentication: Revolutionizing Identification, Adulterant Detection and Standardization]]></title><link>https://www.benthamscience.com/article/148952</link><pubDate>2026-03-31</pubDate><description><![CDATA[<p> Introduction: Pharmaceutical companies widely use herbals as the main ingredients in formulations. Nevertheless, conventional techniques for herbal identification, like morphological and microscopic identification, are labor-based, require expertise, and are time-consuming. These challenges hamper the identification and quality control of herbals. </p> <p> Objective: This review explores the utilization of a computer-based model in the recognition and quality control of herbals and their adulterants. The study highlights artificial intelligence's power to transform the herbal industry by improving quality control, therapeutic reproducibility, and stakeholder accessibility. </p> <p> Methods: The paper examines recent advanced computational methods for identifying herbals. Artificial intelligence addresses issues such as data complications and adulterant recognition. The paper also compares artificial intelligence-based methods with traditional approaches, focusing on their benefits in speed, cost-effectiveness, and precision. </p> <p> Results and Discussion: Artificial intelligence methods show significant power in the herbal field. Their use improves herbal recognition, adulterant discovery, and quality assurance by leveraging data-driven algorithms. Moreover, artificial intelligence decreases laboratory expenses and increases the convenience and suitability of herbals. </p> <p> Conclusion: Artificial intelligence provides transformative solutions for the herbal industry by addressing venerable challenges in herbal identification and adulterant detection. Its interdisciplinary approach promises better regularity, increased remedial outcomes, and increased trust of consumers. </p>]]></description> </item><item><title><![CDATA[Exploring a Decade of Homomorphic Encryption: Advancements, Challenges, and Future Directions]]></title><link>https://www.benthamscience.com/article/150700</link><pubDate>2026-03-31</pubDate><description><![CDATA[<p> Homomorphic encryption (HE) enables secure computations on encrypted data without decryption, offering a transformative solution for privacy-preserving computation. This review presents a ten-year retrospective (2014–2024) on HE’s evolution since Gentry’s 2009 fully homomorphic encryption (FHE) scheme, which introduced the concept of performing arbitrary computations on ciphertexts. Early schemes were hindered by inefficiencies like computational overhead and noise accumulation. </p> <p> Over the past decade, significant advancements have addressed these barriers. Schemes such as BGV, BFV, and CKKS have been developed for efficient integer and approximate real-number computations. Algorithmic innovations like optimized bootstrapping and improved noise management have reduced complexity. Hardware acceleration using GPUs and FPGAs has enhanced performance, while integration with secure multi-party computation and zero-knowledge proofs has broadened HE’s applicability. </p> <p> Applications now span privacy-preserving machine learning, genomic data analysis, and financial analytics. Toolkits such as SEAL, HElib, and PALISADE have improved accessibility for developers and researchers. Despite progress, challenges remain, including balancing efficiency and security, and improving usability for non-experts. </p> <p> The article also explores HE’s reliance on lattice-based problems like Learning With Errors (LWE) and Ring-LWE, which provide quantum resistance. As hybrid cryptographic models emerge, HE is increasingly recognized as a key component in securing sensitive data in the postquantum era. </p> <p> This review highlights HE’s maturation from a theoretical concept to a practical solution, demonstrating its potential as a cornerstone for secure, privacy-preserving computing across industries. </p>]]></description> </item><item><title><![CDATA[Advanced IoT Communication Protocols: Driving Health Science Forward]]></title><link>https://www.benthamscience.com/article/150701</link><pubDate>2026-03-31</pubDate><description><![CDATA[This mini-review synthesizes current communication protocols used in IoT-based healthcare, compares their technical features and healthcare applications, and identifies gaps in scalability, security, and real-time performance. The Internet of Things (IoT) is revolutionizing healthcare by enhancing communication and enabling the exchange of real-time data between devices, systems, and healthcare providers. This article examines the crucial role of communication protocols, including Bluetooth, Zigbee, Wi-Fi, NFC, and 5G, in advancing the health sciences. These technologies facilitate remote patient monitoring, telemedicine, smart implants, and medication adherence systems, ultimately improving patient care and outcomes. However, data security, privacy, interoperability, latency, and scalability must be addressed to ensure the successful integration of IoT. The future of IoT in health sciences is bright, with AI, blockchain, and edge computing poised to enhance diagnostics, data security, and decision-making. As IoT continues to evolve, it promises to make healthcare more accessible, efficient, and personalized, shaping a healthier future. The review identifies Zigbee and BLE as low-power protocols suited for personal health monitoring, while Wi-Fi and 5G offer high bandwidth for hospital and remote surgical environments.]]></description> </item><item><title><![CDATA[Using Artificial Intelligence in Engineering Complex Systems]]></title><link>https://www.benthamscience.com/article/151389</link><pubDate>2026-03-31</pubDate><description><![CDATA[<p> The systems engineering process for designing complex products and services decomposes a complex problem into multiple well-defined technical problems solvable by specialists. Systems engineering then integrates these individual solutions into a cohesive, functional response to the complex problem. The process involves defining requirements for the complex problem, translating those requirements into requirements for more well-defined technical problems, verifying and integrating the solutions, and tracking how well the integrated solution addresses the complex problem. Requirement management and model-based systems engineering software are used to develop use cases, translate them into requirements, track those requirements, etc. Separate software packages are needed for data analysis, architecture selection and verification, and method selection. </p> <p> This paper focuses on how AI can enhance systems engineering. Historical experience has shown that the successful introduction of a new technology, e.g., manufacturing robots, requires that existing processes be re-engineered to leverage the advances of that technology. This paper presents a re-engineering framework of the four stages of systems engineering, highlighting opportunities for the effective integration of artificial intelligence. </p>]]></description> </item><item><title><![CDATA[ALZ-Network and ADDS: An Empirical Deep Learning Framework for Alzheimer’s Diagnosis with a Comparative Study of Pretrained Models]]></title><link>https://www.benthamscience.com/article/152056</link><pubDate>2026-03-31</pubDate><description><![CDATA[<p> Introduction: Alzheimer’s Disease (AD) is a progressive, incurable ailment of the Central Nervous System (CNS) that leads to the deterioration of cognitive functions, including memory, reasoning, and behavior. </p> <p> Methods: In this study, a Convolutional Neural Network (CNN) architecture, named ALZNetwork, is proposed for diagnosing Alzheimer’s Disease (AD). The model’s robustness lies in its training on a single dataset and testing on two different Magnetic Resonance Imaging (MRI) datasets, both consisting of 2D slices from Alzheimer’s Disease Neuroimaging Initiative (ADNI) sources, achieving impressive results. There were two main objectives of this research: (1) to create a novel 2D image dataset, and (2) to construct a robust convolutional framework on this dataset for AD diagnosis. </p> <p> Results: Comparisons were made between the ALZ-Network model and its pre-trained counterparts, i.e., Xception, InceptionV3, and EfficientNetB0. Model evaluation was done on a 3-class classification problem using standard metrics, i.e., accuracy, positive predictive value, sensitivity, and the harmonic mean of the latter two. InceptionV3 and Xception models achieved reduced training time with classification accuracies of 91.69% and 97.68%, respectively, whereas EfficientNetB0 and ALZ-Network achieved higher classification accuracies of 99.32% and 99.70%, respectively. </p> <p> Discussion: A web platform, i.e., Alzheimer’s Disease Detection System (ADDS), built on the proposed architecture and other models, was created (run on a local machine) to test unseen 2D images of AD. </p> <p> Conclusion: This platform can assist radiologists in screening for potential Alzheimer’s disease from MRI scans of subjects. </p>]]></description> </item><item><title><![CDATA[A Spine CT Image Segmentation Method based on an Improved U-Net]]></title><link>https://www.benthamscience.com/article/151319</link><pubDate>2026-03-31</pubDate><description><![CDATA[<p> Introduction: Spine CT image segmentation is challenging due to issues such as tissue mixing, low contrast, and edge blurring, which often lead to unsatisfactory results. </p> <p> Method: This paper proposes the RSAFF network, which incorporates a residual self-attention module to enhance edge information extraction and an RFA_a module for feature recalibration and gradient preservation. </p> <p> Results: The proposed method achieved a dice similarity coefficient of 91.52% on the test set, exceeding U-Net by 2.01% and outperforming other comparative models. </p> <p> Discussion: The improvement can be attributed to the enhanced ability to capture fine anatomical structures and edge details through self-attention and feature fusion mechanisms. </p> <p> Conclusion: The RSAFF model demonstrates significant potential for improving the accuracy of spine CT image segmentation in clinical applications. </p>]]></description> </item></channel></rss>